据新天水，记者从甘肃省卫生健康委获悉，为全面提升天水市第二人民医院医疗卫生服务水平， 由 甘肃省人民医院全面托管天水市第二人民医院，省人民医院原党委书记、主任医师李兴勇担任天水市 第二人民医院党委副书记、院长。 相关阅读： 甘肃通报：褐石培心幼儿园餐食铅含量严重超标 6人被批捕 17人被立案审查调查 另据了解，天水市第二人民医院重新购置国内最新的血铅检验设备。目前已完成设备安装调试、计量 检定、比对验证和人员培训，3名省级检验专家入驻开展血铅检验工作，具备快速准确进行血铅检验 的能力。 同时，选派省人民医院普外科主任医师何锦担任天水市第二人民医院党委副书记、副院长，选派36 名儿科、中毒治疗、消化、心理卫生、检验等省级专家长期入驻天水市第二人民医院开展诊疗服务。 李兴勇，男，1963年8月生，中共党员，毕业于兰州医学院医疗系，医学硕士，天津中医药大学硕 士研究生导师，甘肃中医药大学博士研究生导师，省政府参事，享受国务院特殊津贴专家、甘肃省五 一劳动奖章获得者。 ...

首例零射线心脏 手术成功！疏附 县人民医院实现 微创诊疗新突破 _南方+_南方 plus "感谢你们的细 心治疗！"日 前，疏附县群众 靳某及家人将一 面印有"仁心仁 术解病忧 医德 高尚誉九州"的 锦旗送到了县人 民医院，以感谢 心内科林晓圳医 生及全体医护人 员。这份感谢源 于疏附县人民医 院成功实施的首 例零射线室上性 心动过速 （SVT）射频消 融术。 6月下旬，患者 靳某因心悸发作 入院，经过心电 疏附群众将一面锦旗送到了县人民医院，感谢医护人员。 图确诊为室上 速，广州医疗援 疆专家林晓圳带 领心内科团队对 患者的病情进行 了慎密的分析， 认为射频消融术 了很长一段时 间。"一直拖着 没去治疗的原 因，就是听人说 治疗室上速的技 术只有一线大城 市的医院才能开 展。当我得知疏 附县人民医院能 开展这方面的手 术，就赶紧来进 行治疗。"他 说。 此次介入手术室 首例零射线室上 性心动过速 （SVT）射频消 融术的成功开 展，标志着疏附 县人民医院微创 诊疗技术迈入全 新阶段，彰显了 科室在心脏电生 理专业的技术实 力跃升，更意味 着区域内心律失 常患者从此可 在"家门口"获得 达到国内先进水 平的治 ...

Core Viewpoint - The successful completion of the third kidney transplant assisted by the Da Vinci robot at Yantai Yuhuangding Hospital marks a significant breakthrough in complex organ transplantation in China, providing new treatment pathways for patients with end-stage kidney disease globally [1][11][13]. Group 1: Surgical Achievement - The surgery was performed by a collaborative team led by Director Yu Shengqiang from the organ transplant department and Director Wu Jitao from the urology department, under the guidance of Professor Gao Zhenli [1][11]. - The patient, Mr. Wang, had undergone two previous kidney transplants and faced high surgical difficulty and rejection risks due to extensive adhesions and weakened tissues from prior surgeries [7][11]. - The use of the Da Vinci robot significantly reduced surgical trauma and patient burden, allowing for precise operations in a challenging environment [7][13]. Group 2: Innovative Approach - The surgical team faced a lack of prior literature or practical experience regarding the use of the Da Vinci robot for a third kidney transplant, necessitating independent exploration and innovation [11][13]. - A comprehensive pre-surgical plan was developed, including individualized immunosuppressant protocols and detailed monitoring strategies to minimize rejection risks [11][13]. - The team utilized advanced techniques to navigate the complex anatomical challenges presented by the patient's previous surgeries, demonstrating a high level of surgical skill and innovation [11][13]. Group 3: Broader Implications - The success of this surgery not only saved the patient's life but also showcased the hospital's capability to tackle complex transplant challenges using cutting-edge technology [13]. - This achievement is expected to have significant clinical implications, providing valuable experience and a successful model for similar complex cases globally [13]. - The hospital's efforts reflect a commitment to advancing minimally invasive surgical techniques and contributing to the global medical community's understanding of complex organ transplants [13].

齐鲁晚报.齐鲁壹点孙淑玉通讯员李成修王婧 近日，烟台毓璜顶医院传来好消息，郑磊教授团队在心脏瓣膜疾病治疗领域再度取得重大突破，成功运用中国首款国产球扩瓣Prizvalve 瓣膜，完成我国北方首例高难度的经导管三尖瓣"瓣中瓣"手术(TVIV)，为生物瓣衰败患者重新撑开"心"门，带来了生的希望。 郑磊(右1)团队讨论患者病情 面对如此复杂且高危的病情，郑磊教授团队迅速组织了多轮深入讨论和全面评估。经过反复权衡利弊，结合患者的具体情况，该团队决 定摒弃传统开胸手术，采用介入"瓣中瓣"手术方式。"我们希望通过这种微创手段，在降低手术风险的同时，为患者带来更好的治疗效 果。"郑磊说。 精准手术：高超技艺与先进器械完美融合 经过周密的术前规划和入路模拟，手术如期开展。郑磊教授团队经右股静脉入路，导管配合导丝小心翼翼地跨瓣。"为确保导丝的稳定 性，导丝成功跨瓣后，被精准地置于肺动脉远端。"郑磊介绍说，右房扩张导致输送系统贴靠性较差，瓣膜轴向不佳，给手术增加了不小 的难度。 手术团队合影 病情棘手：高龄患者再陷心脏困境 患者李先生(化姓)今年68岁，38年前行二尖瓣外科闭式扩张术，19年前又进行了二尖瓣机械瓣置换、三尖瓣生物 ...

Core Viewpoint - Public hospitals are essential to China's healthcare system and play a significant role in promoting high-quality healthcare development through specialized departments, particularly in ophthalmology [1][2]. Group 1: Strengthening Specialized Departments - The primary task for advancing public hospitals' high-quality development is to strengthen specialized departments, with the Shenyang Fourth People's Hospital focusing on ophthalmology to enhance overall hospital performance [2]. - The ophthalmology department is a clinical key specialty in Liaoning Province, addressing complex eye injuries and congenital retinal diseases, thereby improving regional healthcare capabilities [2][3]. - The hospital aims to share its successful experiences in ophthalmology with other departments to provide better healthcare services to the public [2]. Group 2: Day Surgery Model - The day surgery model offers significant advantages over traditional surgery, including improved patient experience, reduced economic costs, and enhanced medical service quality [4]. - This model reduces hospital bed demand and allows more patients to receive care, although it requires a shift in mindset from medical staff and addresses patient concerns about post-operative care [4][5]. - The hospital has implemented measures to promote the day surgery model, including comprehensive patient management, strict surgeon qualifications, and standardized treatment processes to ensure safety and quality [5]. Group 3: Comprehensive Disease Management - Comprehensive disease management is crucial for improving patient outcomes and quality of life, with the hospital establishing a closed-loop system for screening, treatment, and management [6][7]. - The hospital conducts screenings for high-risk groups using AI technology to identify potential eye diseases early, particularly diabetic retinopathy [7]. - Personalized treatment plans are provided, and AI systems are utilized for follow-up care, enhancing patient adherence to treatment and overall health management [7].

Core Viewpoint - The article highlights the concerning trend of mandatory facial recognition in hospitals, with half of the surveyed top-tier hospitals in Guangzhou requiring patients to use facial recognition for initial registration, raising issues of privacy and compliance with existing laws [1][2][4]. Group 1: Regulatory Context - The implementation of the "Facial Recognition Technology Application Security Management Measures" in June established core principles for handling facial information, emphasizing "clear purpose, minimum necessity, and strict protection" [1]. - Previous laws, such as the Civil Code and the Personal Information Protection Law, have already set clear guidelines on the use of personal information, requiring that facial recognition not be the sole method of verification [1][2]. Group 2: Hospital Practices - The study found that hospitals, particularly Guangzhou Medical University Affiliated Second and Third Hospitals, enforced strict facial recognition policies, which may not fully inform patients about the use of their facial data [1][4]. - The article argues that hospitals, as public service providers, should demonstrate a higher level of legal compliance and awareness regarding the use of facial recognition technology [3]. Group 3: Enforcement and Governance - The article stresses the need for effective enforcement of laws regarding facial recognition, suggesting that regulatory bodies must actively supervise and respond to public complaints, especially in healthcare settings where patients may struggle to protect their rights [3][4]. - It calls for the involvement of judicial authorities to ensure that hospitals do not become blind spots in the enforcement of personal information protection laws [4].

Core Viewpoint - The establishment of the oncology medical alliance between Tongji Hospital and Tengzhou Central People's Hospital represents a significant opportunity for the development of oncology disciplines, enhancing diagnostic capabilities, research levels, and regional influence in healthcare [1][8]. Group 1 - The unveiling ceremony of the oncology medical alliance took place at Tengzhou Central People's Hospital, attended by key figures from both hospitals [1]. - Zhu Guangyao emphasized the importance of joining the oncology medical alliance, highlighting the potential for improved diagnostic and treatment capabilities through collaboration with Tongji Hospital's advanced resources [1][3]. - The alliance aims to promote resource sharing, complementary advantages, and collaborative development, focusing on multi-center clinical trials and the transformation of research outcomes [3]. Group 2 - The unveiling of the "Tongji Hospital Oncology Medical Alliance Member Unit" was conducted by Yuan Xianglin and Zhu Guangyao, followed by academic exchanges on various oncology research projects [6]. - The collaboration will create a high-level platform for Tengzhou Central People's Hospital's oncology discipline, enhancing cooperation in research innovation, talent cultivation, and technical improvement [8].

Core Points - Beijing Tongren Hospital has launched a comprehensive pediatric ophthalmology diagnosis and treatment center to address the needs of children with eye diseases during peak periods such as summer vacations and weekends [1] - The center integrates various medical resources including ophthalmology, pediatrics, anesthesia, and imaging, streamlining the process from appointment scheduling to pre-operative preparations [1] - The center aims to reduce the average pre-operative preparation time from 7-10 days to 2-3 days by implementing a mechanism for simultaneous examinations, assessments, and scheduling [1] - In 2024, pediatric surgeries are expected to account for 11% of all ophthalmic surgeries at the hospital, with pediatric outpatient visits making up 35% of total outpatient visits [1] - The center will also establish a leading pediatric ophthalmology research base in China, focusing on the integration of clinical and basic research, and the development of specialized diagnostic equipment and AI-assisted diagnostic systems [2] Summary by Categories Service Enhancement - The pediatric ophthalmology center operates seven days a week to meet the increased demand during holidays and weekends [1] - The center's operational model allows for seamless coordination of pre-operative checks, pediatric consultations, anesthesia evaluations, and surgical arrangements [1] Research and Development - The center will promote the translation of research findings into clinical applications, particularly in developing specialized diagnostic equipment and AI systems for conditions like myopia, strabismus, amblyopia, and rare eye diseases [2] Patient Access - Patients can book appointments through the Beijing Tongren Hospital WeChat mini-program, with availability across different locations [2]

Group 1 - The meeting held on July 8 at the Affiliated Heji Hospital of Changzhi Medical College involved the appointment of Hao Shaofeng as the new Party Secretary of the hospital, replacing his previous role as Deputy Party Secretary and President [2] - The Affiliated Heji Hospital, established in August 1999, is a comprehensive tertiary hospital that integrates medical care, teaching, research, prevention, and rehabilitation, serving as a core base for clinical teaching at Changzhi Medical College [2] - The hospital currently operates under a "one hospital, two areas" development model, with the North Campus having 320 authorized beds and 300 open beds, covering an area of 18,673 square meters and a building area of 19,000 square meters [2] - The new North Campus is expected to be fully operational by January 2025, with a total land area of 69,470.04 square meters (approximately 104.21 acres) and a total building area of 76,800 square meters, significantly increasing the number of open beds to 500 [2]

Summary of the Conference Call for Sanbo Brain Science Company Overview - **Company**: Sanbo Brain Science - **Industry**: Healthcare, specifically focusing on brain-machine interface technology and neurosurgery Key Points and Arguments Financial Performance - **Revenue Stability**: Revenue for the first half of the year remained flat compared to the previous year, with growth observed in Beijing, Henan, and Fujian regions, while Kunming faced challenges due to relocation [2][3] - **Profit Growth**: Expected single-digit profit growth attributed to supply chain optimization and contributions from newly acquired hospitals, with the Chengdu hospital maintaining positive profitability [2][3] Technological Advancements - **Clinical Trials**: Successful completion of an interventional brain-machine interface trial in Fujian, with plans for another trial in Beijing [2][5] - **Research Collaboration**: Joint research projects with universities focusing on early-stage technology research for epilepsy and Parkinson's disease, with minimal fees charged [10][11] New Hospital Developments - **New Facilities**: Progress on new hospital locations, with the Beijing facility expected to relocate in Q1 2025, and the Kunming facility now operational after relocation [2][6] Industry Challenges - **Impact of DRG Payment System**: The implementation of the DRG (Diagnosis-Related Group) payment system has led to a decrease in inpatient costs by approximately 10%, necessitating an increase in patient volume to offset revenue losses [4][16] - **Market Dynamics**: A shift in patient preferences towards pharmacies and clinics due to perceived cost-effectiveness, impacting hospital visit numbers [16] Future Growth Strategies - **M&A Fund**: Establishment of a 300 million yuan merger and acquisition fund aimed at acquiring and incubating hospitals, with contributions from the company, local governments, and large pharmaceutical companies [4][13] - **Expansion Plans**: Plans to expand into the Yangtze River Delta and Pearl River Delta regions through acquisitions, with a focus on enhancing operational efficiency and service quality [16][17] Clinical Application of Brain-Machine Interface Technology - **Current Status**: The technology is in the early clinical validation stage, primarily focused on experimental verification, with applications in neuro-regulation for conditions like Parkinson's disease and epilepsy [7][9] Talent Acquisition and Incentives - **Attracting Talent**: The hospital offers flexible mechanisms and equity incentives to attract core experts, providing significant career advancement opportunities compared to traditional public hospitals [18][19] Collaboration with Universities - **Resource Utilization**: Collaboration with universities to leverage resources for research and teaching, ensuring high-quality support for clinical and academic endeavors [20] Financial Management of Acquisitions - **Risk Management**: Contracts for new acquisitions include provisions for potential risks such as Medicare deductions and legal disputes, ensuring effective management of hidden liabilities [26] Additional Important Information - **AI Integration**: Current clinical and management operations have not fully integrated AI models, with a cautious approach towards evaluating the effectiveness of such technologies [22][23] - **Patient Volume Trends**: Observations indicate a decline in hospital visits, with a notable increase in business for clinics and pharmacies [16][24] This summary encapsulates the key insights from the conference call, highlighting the company's performance, strategic initiatives, and industry challenges.